Matterworks - About the company
Matterworks is a series A company based in Somerville (United States), founded in 2019 by Mimoun Cadosch Delmar. It operates as an AI and analytical platform to accelerate therapeutic research. Matterworks has raised $15.9M in funding from Lewis & Clark Partners and OMX Ventures. The company has 26 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Enterome, Moleculent and Vizzhy.
Company Details
AI and analytical platform to accelerate therapeutic research. The company has developed the Large Spectral Model and Pyxis, a product that enables scalable quantitative metabolomics with AI. It has ability to identify and quantify features from raw untargeted data, providing quantitative results automatically.
- Website
- www.matterworks.ai/
Key Metrics
Founded Year
2019
Location
Somerville, United States
Stage
Series A
Total Funding
$15.9M in 4 rounds
Latest Funding Round
Investors
Ranked
1st among 26 active competitors
Employee Count
45 as on May 31, 2026
Similar Companies
Legal entities associated with Matterworks
Matterworks is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MATTERWORKS, INC. CIN: 842436414 , United States, Active | Dec 31, 1999 | - | 22 (As on Dec 31, 2024) | - |
Sign up to download Matterworks' company profile
Matterworks's funding and investors
Matterworks has raised a total funding of $15.9M over 4 rounds. Its first funding round was on Aug 04, 2020. Its latest funding round was a Series A round on Jun 03, 2025 for $*****. 6 investors participated in its latest round. Matterworks has 9 institutional investors.
Here is the list of recent funding rounds of Matterworks:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 03, 2025 | 6130996 | Series A | 8029551 | 7372543 | 2038095 | 7722022 |
Mar 15, 2022 | 7470825 | Series A | 8824510 | 2141427 | 7145533 | |
Nov 12, 2020 | 8567596 | Series A | 1027945 | 5728936 | 1913027 |
View details of Matterworks's funding rounds and investors
Matterworks' founders and board of directors
Founder? Claim ProfileThe founders of Matterworks is Mimoun Cadosch Delmar.
Here are the details of Matterworks' key team members:
- Mimoun Cadosch Delmar: Former Co-Founder of Matterworks.
View details of Matterworks's Founder profiles and Board Members
Matterworks' employee count trend
Matterworks has 45 employees as of May 26. Here is Matterworks's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Matterworks's Competitors and alternates
Top competitors of Matterworks include Enterome, Moleculent and Vizzhy. Here is the list of Top 10 competitors of Matterworks, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Matterworks 2019, Somerville (United States), Series A | AI and analytical platform to accelerate therapeutic research | $15.9M | 60/100 | |
2nd | Developer of immunomodulatory drugs targeting cancer and immune diseases | $130M | 58/100 | ||
3rd | Moleculent 2019, Solna (Sweden), Series A | Provider of a biology platform that detects cell-cell interactions within their tissue environment | $26M | 46/100 | |
4th | Vizzhy 2019, Austin (United States), Seed | Provider of multi omics based metabolic signature program and solutions for metabolic health issues | - | 44/100 | |
5th | Leman Biotech 2021, Shenzhen (China), Series A | Develope rof AI-based platform for cancer immunotherapy | $13.9M | 36/100 | |
6th | Oria Bioscience 2024, Paris (France), Unfunded | Provider of AI tools and drug screening based on human cells and organoids | - | - | 30/100 |
7th | Provider of mitochondrial screening platform for diagnostics | $20K | 28/100 | ||
8th | Terra Bioworks 2021, Middleton (United States), Unfunded | Platform for drug discovery and development | - | - | 24/100 |
9th | Cytoscape 2002, Seattle (United States), Unfunded | Developer of platform for visualizing molecular interaction networks and biological pathways | - | - | 24/100 |
10th | Noumea Bio 2022, United States, Unfunded | Provider of a platform for development of drugs | - | - | 24/100 |
Looking for more details on Matterworks's competitors? Click here to see the top ones
Matterworks's Investments and acquisitions
Matterworks has made no investments or acquisitions yet.
Reports related to Matterworks
Here is the latest report on Matterworks's sector:
News related to Matterworks
Media has covered Matterworks for a total of 2 events in the last 1 year.
•
MATTERWORKS INC. Secures Series A Funding to Advance Machine Intelligence for Predictive Biologyintelligence360•Jun 13, 2025•Matterworks, Lewis & Clark Partners, OMX Ventures, Pillar VC and 3 others
•
•
Matterworks Announces Updates To Leadership TeamPR Newswire•May 02, 2024•Matterworks, Novartis, Cohere Health
•
•
Are you a Founder ?
FAQs about Matterworks
Explore our recently published companies
- Landrisklogistics.com - Unfunded company
- HolyPoly - United States based, 2026 founded, Unfunded company
- Signo.ai - 2024 founded, Unfunded company
- Winsped.pl - Poland based, Unfunded company
- Varden.com - 2000 founded, Unfunded company
- Cloveroptimization.com - Unfunded company
